Dr. Matthew Ballo on WREG for Skin Cancer Awareness

Posted by & filed under Uncategorized.

Radiation Oncologist, Dr. Matthew Ballo, was recently featured on WREG News Channel 3‘s “3 Good Minutes” to share information about sun safety and updates in skin cancer treatments and research! He shares “Taking care of your skin and avoiding skin cancer is kind of like taking care of your car. You need to do regular… Read more »

Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »

ASCO 2021: Abstract Recommendations From Dr. Ari VanderWalde for Melanoma

Posted by & filed under Uncategorized.

Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents

Posted by & filed under Uncategorized.

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents   Written by Ari VanderWalde MD, MPH, FACP   Despite a plethora of interesting findings and results of novel clinical trials in melanoma in 2020, I believe the most important story of the year was actually a small, easy-to-overlook, 3-page report in the American… Read more »